Similar centers already operate in Russia and Ukraine. The Belarusian facility will have a higher throughput capacity and advanced technologies. Oleg Sukonko noted that, in essence, it will be a factory producing short-lived isotopes. The isotopes will be attached to a glucose molecule and injected into the body. Then the equipment will register the signal emitted by the isotope. Thus, it will be possible to find out whether the treatment of the patient is going well. …read more
Source: BELTA
